Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Non-small Cell Lung Cancer (NSCLC), Ovarian Cancer, or Breast Cancer
Clinical trial NCT03937154 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03937154
- Sponsor
- Amgen
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-02-26
- Primary completion
- 2026-03-10
- Enrollment
- 145
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.